439 related articles for article (PubMed ID: 18483232)
61. Contrast-induced acute kidney injury (CI-AKI) following intra-arterial administration of iodinated contrast media.
Karlsberg RP; Dohad SY; Sheng R;
J Nephrol; 2010; 23(6):658-66. PubMed ID: 20540038
[TBL] [Abstract][Full Text] [Related]
62. The relative renal safety of iodixanol compared with low-osmolar contrast media: a meta-analysis of randomized controlled trials.
Reed M; Meier P; Tamhane UU; Welch KB; Moscucci M; Gurm HS
JACC Cardiovasc Interv; 2009 Jul; 2(7):645-54. PubMed ID: 19628188
[TBL] [Abstract][Full Text] [Related]
63. Iso-osmolar contrast medium better preserves short- and long-term renal function after cardiovascular catheterizations in patients with severe baseline renal insufficiency.
Hsieh YC; Liu TJ; Liang KW; Her HY; Lin WW; Wang KY; Chen YT; Ting CT; Lee WL
Int J Cardiol; 2006 Jul; 111(1):182-4. PubMed ID: 16624433
[TBL] [Abstract][Full Text] [Related]
64. Changes of renal water diffusion coefficient after application of iodinated contrast agents: effect of viscosity.
Jost G; Lenhard DC; Sieber MA; Lengsfeld P; Hütter J; Pietsch H
Invest Radiol; 2011 Dec; 46(12):796-800. PubMed ID: 21808199
[TBL] [Abstract][Full Text] [Related]
65. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.
Jo SH; Youn TJ; Koo BK; Park JS; Kang HJ; Cho YS; Chung WY; Joo GW; Chae IH; Choi DJ; Oh BH; Lee MM; Park YB; Kim HS
J Am Coll Cardiol; 2006 Sep; 48(5):924-30. PubMed ID: 16949481
[TBL] [Abstract][Full Text] [Related]
66. Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) - a clinical problem in daily practice? A multicenter observational study.
Lencioni R; Fattori R; Morana G; Stacul F
Acta Radiol; 2010 Sep; 51(7):741-50. PubMed ID: 20707658
[TBL] [Abstract][Full Text] [Related]
67. Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization.
Artunc FH; Fischer IU; Risler T; Erley CM
Int J Cardiol; 2005 Jul; 102(2):173-8. PubMed ID: 15982481
[TBL] [Abstract][Full Text] [Related]
68. Renal Insufficiency Following Radiocontrast Exposure Trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy.
Adolph E; Holdt-Lehmann B; Chatterjee T; Paschka S; Prott A; Schneider H; Koerber T; Ince H; Steiner M; Schuff-Werner P; Nienaber CA
Coron Artery Dis; 2008 Sep; 19(6):413-9. PubMed ID: 18955835
[TBL] [Abstract][Full Text] [Related]
69. Comparative investigation of i.v. iohexol and iopamidol: effect on renal function in low-risk outpatients undergoing CT.
Dillman JR; al-Hawary M; Ellis JH; Cohan RH; Kaza R; Myles JD; Khalatbari S; Francis IR
AJR Am J Roentgenol; 2012 Feb; 198(2):392-7. PubMed ID: 22268183
[TBL] [Abstract][Full Text] [Related]
70. N-Acetylcysteine added to volume expansion with sodium bicarbonate does not further prevent contrast-induced nephropathy: results from the cardiac angiography in renally impaired patients study.
Staniloae CS; Doucet S; Sharma SK; Katholi RE; Mody KR; Coppola JT; Solomon R
J Interv Cardiol; 2009 Jun; 22(3):261-5. PubMed ID: 19490358
[TBL] [Abstract][Full Text] [Related]
71. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trial.
Carraro M; Malalan F; Antonione R; Stacul F; Cova M; Petz S; Assante M; Grynne B; Haider T; Palma LD; Faccini L
Eur Radiol; 1998; 8(1):144-7. PubMed ID: 9442148
[TBL] [Abstract][Full Text] [Related]
72. Angiography with nonionic X-ray contrast media in severe chronic renal failure: renal function and contrast retention.
Jakobsen JA; Berg KJ; Kjaersgaard P; Kolmannskog F; Nordal KP; Nossen JO; Rootwelt K
Nephron; 1996; 73(4):549-56. PubMed ID: 8856250
[TBL] [Abstract][Full Text] [Related]
73. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.
McDonald JS; McDonald RJ; Carter RE; Katzberg RW; Kallmes DF; Williamson EE
Radiology; 2014 Apr; 271(1):65-73. PubMed ID: 24475854
[TBL] [Abstract][Full Text] [Related]
74. Significant perturbation in renal functional magnetic resonance imaging parameters and contrast retention for iodixanol compared with iopromide: an experimental study using blood-oxygen-level-dependent/diffusion-weighted magnetic resonance imaging and computed tomography in rats.
Wang YC; Tang A; Chang D; Zhang SJ; Ju S
Invest Radiol; 2014 Nov; 49(11):699-706. PubMed ID: 24879299
[TBL] [Abstract][Full Text] [Related]
75. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.
Briguori C; Airoldi F; D'Andrea D; Bonizzoni E; Morici N; Focaccio A; Michev I; Montorfano M; Carlino M; Cosgrave J; Ricciardelli B; Colombo A
Circulation; 2007 Mar; 115(10):1211-7. PubMed ID: 17309916
[TBL] [Abstract][Full Text] [Related]
76. Retention of iodine and expression of biomarkers for renal damage in the kidney after application of iodinated contrast media in rats.
Jost G; Pietsch H; Sommer J; Sandner P; Lengsfeld P; Seidensticker P; Lehr S; Hütter J; Sieber MA
Invest Radiol; 2009 Feb; 44(2):114-23. PubMed ID: 19104440
[TBL] [Abstract][Full Text] [Related]
77. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media.
McCullough PA; Bertrand ME; Brinker JA; Stacul F
J Am Coll Cardiol; 2006 Aug; 48(4):692-9. PubMed ID: 16904536
[TBL] [Abstract][Full Text] [Related]
78. Renal safety in pediatric imaging: randomized, double-blind phase IV clinical trial of iobitridol 300 versus iodixanol 270 in multidetector CT.
Zo'o M; Hoermann M; Balassy C; Brunelle F; Azoulay R; Pariente D; Panuel M; Le Dosseur P
Pediatr Radiol; 2011 Nov; 41(11):1393-400. PubMed ID: 21713440
[TBL] [Abstract][Full Text] [Related]
79. A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients.
Dussol B; Morange S; Loundoun A; Auquier P; Berland Y
Nephrol Dial Transplant; 2006 Aug; 21(8):2120-6. PubMed ID: 16611682
[TBL] [Abstract][Full Text] [Related]
80. Proof of principle: hydration by low-osmolar mannitol-glucose solution alleviates undesirable renal effects of an iso-osmolar contrast medium in rats.
Seeliger E; Ladwig M; Sargsyan L; Cantow K; Persson PB; Flemming B
Invest Radiol; 2012 Apr; 47(4):240-6. PubMed ID: 22353855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]